Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - TOTAL CURRENT ASSETS
Total Current Assets ANAB - AnaptysBio, Inc.
407 M
LAST VALUE
-14.30%
2 YEAR CAGR
-1.29%
5 YEAR CAGR
63.10%
10 YEAR CAGR